Bioactivity of strontium-monetite coatings for biomedical applications

Daniel Navarro da Rocha, Leila Rosa de Oliveira Cruz, José Brant de Campos, Jheison Lopes dos Santos, Rubens L.Santana Blazutti Marçal, Dindo Q. Mijares, Rafael Maza Barbosa, Paulo Coelho, Marcelo H. Prado da Silva

Research output: Contribution to journalArticle

Abstract

The bioactivity of calcium phosphate (CaP) coatings can be controlled by different CaP phase precipitation and/or addition of foreign ions to their crystal lattice. Cationic substitution of strontium (Sr) into CaP coatings has gained a great attention due to the unique potential of Sr ions on stimulating new bone formation while inhibiting bone resorption. In this study, a novel route was used for producing Sr-substituted calcium phosphate coating on metallic substrates, containing 5 mol%, 10 mol% and 15 mol% Sr concentration, by chemical deposition method. The obtained Sr-substituted calcium phosphate coatings were structurally characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) analyses. The presence of strontium ions into calcium phosphate phase fostered monetite precipitation, instead of brushite, and this cationic substitution was investigated by Rietveld refinement method. FEG-SEM analysis showed the bioactivity behavior by the precipitation of characteristic bone-like apatite on the 5% Sr-monetite and HA coatings after 14 days of incubation, using McCoy culture medium. The biological performance of the coated surfaces showed that hDPSCs viability was enhanced in the presence of Sr2+ ion concentration up to 10 mol% (p < 0.05) when compared to the uncoated titanium substrates and hydroxyapatite coatings. The results suggested the 5% Sr-monetite as a potential alternative for hydroxyapatite coatings, because of the improved biological responses in this study.

Original languageEnglish (US)
JournalCeramics International
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Strontium
Bioactivity
Calcium phosphate
Phosphate coatings
Coatings
Ions
Bone
Durapatite
Hydroxyapatite
Substitution reactions
Apatites
Rietveld refinement
anhydrous dibasic calcium phosphate
Apatite
Substrates
Titanium
Crystal lattices
Fourier transform infrared spectroscopy
Culture Media
calcium phosphate

Keywords

  • B. Surfaces
  • C. Chemical properties
  • D. Apatite
  • E. Biomedical applications

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Ceramics and Composites
  • Process Chemistry and Technology
  • Surfaces, Coatings and Films
  • Materials Chemistry

Cite this

Navarro da Rocha, D., Cruz, L. R. D. O., de Campos, J. B., Santos, J. L. D., Marçal, R. L. S. B., Mijares, D. Q., ... Prado da Silva, M. H. (Accepted/In press). Bioactivity of strontium-monetite coatings for biomedical applications. Ceramics International. https://doi.org/10.1016/j.ceramint.2019.01.051

Bioactivity of strontium-monetite coatings for biomedical applications. / Navarro da Rocha, Daniel; Cruz, Leila Rosa de Oliveira; de Campos, José Brant; Santos, Jheison Lopes dos; Marçal, Rubens L.Santana Blazutti; Mijares, Dindo Q.; Barbosa, Rafael Maza; Coelho, Paulo; Prado da Silva, Marcelo H.

In: Ceramics International, 01.01.2019.

Research output: Contribution to journalArticle

Navarro da Rocha, D, Cruz, LRDO, de Campos, JB, Santos, JLD, Marçal, RLSB, Mijares, DQ, Barbosa, RM, Coelho, P & Prado da Silva, MH 2019, 'Bioactivity of strontium-monetite coatings for biomedical applications', Ceramics International. https://doi.org/10.1016/j.ceramint.2019.01.051
Navarro da Rocha D, Cruz LRDO, de Campos JB, Santos JLD, Marçal RLSB, Mijares DQ et al. Bioactivity of strontium-monetite coatings for biomedical applications. Ceramics International. 2019 Jan 1. https://doi.org/10.1016/j.ceramint.2019.01.051
Navarro da Rocha, Daniel ; Cruz, Leila Rosa de Oliveira ; de Campos, José Brant ; Santos, Jheison Lopes dos ; Marçal, Rubens L.Santana Blazutti ; Mijares, Dindo Q. ; Barbosa, Rafael Maza ; Coelho, Paulo ; Prado da Silva, Marcelo H. / Bioactivity of strontium-monetite coatings for biomedical applications. In: Ceramics International. 2019.
@article{23a8f772291d47689410af78fe78d687,
title = "Bioactivity of strontium-monetite coatings for biomedical applications",
abstract = "The bioactivity of calcium phosphate (CaP) coatings can be controlled by different CaP phase precipitation and/or addition of foreign ions to their crystal lattice. Cationic substitution of strontium (Sr) into CaP coatings has gained a great attention due to the unique potential of Sr ions on stimulating new bone formation while inhibiting bone resorption. In this study, a novel route was used for producing Sr-substituted calcium phosphate coating on metallic substrates, containing 5 mol{\%}, 10 mol{\%} and 15 mol{\%} Sr concentration, by chemical deposition method. The obtained Sr-substituted calcium phosphate coatings were structurally characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) analyses. The presence of strontium ions into calcium phosphate phase fostered monetite precipitation, instead of brushite, and this cationic substitution was investigated by Rietveld refinement method. FEG-SEM analysis showed the bioactivity behavior by the precipitation of characteristic bone-like apatite on the 5{\%} Sr-monetite and HA coatings after 14 days of incubation, using McCoy culture medium. The biological performance of the coated surfaces showed that hDPSCs viability was enhanced in the presence of Sr2+ ion concentration up to 10 mol{\%} (p < 0.05) when compared to the uncoated titanium substrates and hydroxyapatite coatings. The results suggested the 5{\%} Sr-monetite as a potential alternative for hydroxyapatite coatings, because of the improved biological responses in this study.",
keywords = "B. Surfaces, C. Chemical properties, D. Apatite, E. Biomedical applications",
author = "{Navarro da Rocha}, Daniel and Cruz, {Leila Rosa de Oliveira} and {de Campos}, {Jos{\'e} Brant} and Santos, {Jheison Lopes dos} and Mar{\cc}al, {Rubens L.Santana Blazutti} and Mijares, {Dindo Q.} and Barbosa, {Rafael Maza} and Paulo Coelho and {Prado da Silva}, {Marcelo H.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ceramint.2019.01.051",
language = "English (US)",
journal = "Ceramics International",
issn = "0272-8842",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Bioactivity of strontium-monetite coatings for biomedical applications

AU - Navarro da Rocha, Daniel

AU - Cruz, Leila Rosa de Oliveira

AU - de Campos, José Brant

AU - Santos, Jheison Lopes dos

AU - Marçal, Rubens L.Santana Blazutti

AU - Mijares, Dindo Q.

AU - Barbosa, Rafael Maza

AU - Coelho, Paulo

AU - Prado da Silva, Marcelo H.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The bioactivity of calcium phosphate (CaP) coatings can be controlled by different CaP phase precipitation and/or addition of foreign ions to their crystal lattice. Cationic substitution of strontium (Sr) into CaP coatings has gained a great attention due to the unique potential of Sr ions on stimulating new bone formation while inhibiting bone resorption. In this study, a novel route was used for producing Sr-substituted calcium phosphate coating on metallic substrates, containing 5 mol%, 10 mol% and 15 mol% Sr concentration, by chemical deposition method. The obtained Sr-substituted calcium phosphate coatings were structurally characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) analyses. The presence of strontium ions into calcium phosphate phase fostered monetite precipitation, instead of brushite, and this cationic substitution was investigated by Rietveld refinement method. FEG-SEM analysis showed the bioactivity behavior by the precipitation of characteristic bone-like apatite on the 5% Sr-monetite and HA coatings after 14 days of incubation, using McCoy culture medium. The biological performance of the coated surfaces showed that hDPSCs viability was enhanced in the presence of Sr2+ ion concentration up to 10 mol% (p < 0.05) when compared to the uncoated titanium substrates and hydroxyapatite coatings. The results suggested the 5% Sr-monetite as a potential alternative for hydroxyapatite coatings, because of the improved biological responses in this study.

AB - The bioactivity of calcium phosphate (CaP) coatings can be controlled by different CaP phase precipitation and/or addition of foreign ions to their crystal lattice. Cationic substitution of strontium (Sr) into CaP coatings has gained a great attention due to the unique potential of Sr ions on stimulating new bone formation while inhibiting bone resorption. In this study, a novel route was used for producing Sr-substituted calcium phosphate coating on metallic substrates, containing 5 mol%, 10 mol% and 15 mol% Sr concentration, by chemical deposition method. The obtained Sr-substituted calcium phosphate coatings were structurally characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) analyses. The presence of strontium ions into calcium phosphate phase fostered monetite precipitation, instead of brushite, and this cationic substitution was investigated by Rietveld refinement method. FEG-SEM analysis showed the bioactivity behavior by the precipitation of characteristic bone-like apatite on the 5% Sr-monetite and HA coatings after 14 days of incubation, using McCoy culture medium. The biological performance of the coated surfaces showed that hDPSCs viability was enhanced in the presence of Sr2+ ion concentration up to 10 mol% (p < 0.05) when compared to the uncoated titanium substrates and hydroxyapatite coatings. The results suggested the 5% Sr-monetite as a potential alternative for hydroxyapatite coatings, because of the improved biological responses in this study.

KW - B. Surfaces

KW - C. Chemical properties

KW - D. Apatite

KW - E. Biomedical applications

UR - http://www.scopus.com/inward/record.url?scp=85059699310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059699310&partnerID=8YFLogxK

U2 - 10.1016/j.ceramint.2019.01.051

DO - 10.1016/j.ceramint.2019.01.051

M3 - Article

AN - SCOPUS:85059699310

JO - Ceramics International

JF - Ceramics International

SN - 0272-8842

ER -